Barlow Carrolee bought SUPN
February 18, 2026 · Form 4 insider transaction
Barlow Carrolee bought 4,977 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,977
Price
$0.00
Total value
N/A
InsiderBarlow Carrolee
Role—
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after4,977
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each option vests on February 18, 2027.